Form F-6/A - Registration of American Depository Receipt shares, not immediately effective: [Amend]
SEC Accession No. 0001193805-19-001209
Filing Date
2019-10-09
Accepted
2019-10-09 17:05:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 e619113_f6a-innate.htm F-6/A 63319
2 e619113_ex99-a.htm EX-99.(A) 447333
  Complete submission text file 0001193805-19-001209.txt   512244
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

EIN.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6/A

Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Subject) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: F-6/A | Act: 33 | File No.: 333-234063 | Film No.: 191144865
SIC: 2836 Biological Products, (No Diagnostic Substances)